<li>5-htp<p>trazodone and 5-htp both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>abobotulinumtoxina<p>abobotulinumtoxina and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>aceclofenac<p>trazodone, aceclofenac.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>acemetacin<p>trazodone, acemetacin.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>aclidinium<p>aclidinium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>albuterol<p>trazodone increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>alfentanil<p>alfentanil and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>aliskiren<p>trazodone will decrease the level or effect of aliskiren by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>almotriptan<p>almotriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>alprazolam<p>alprazolam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>amikacin<p>trazodone will decrease the level or effect of amikacin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>amisulpride<p>amisulpride and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>amitriptyline<p>trazodone will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>amitriptyline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>amobarbital<p>amobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>amobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>amoxapine<p>amoxapine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amoxapine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>amphetamine<p>amphetamine increases toxicity of trazodone by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>apomorphine<p>trazodone and apomorphine both increase  sedation. Use Caution/Monitor.</p></li><li>aprepitant<p>aprepitant will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>arformoterol<p>trazodone increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>aripiprazole<p>aripiprazole and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>armodafinil<p>armodafinil will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>artemether/lumefantrine<p>artemether/lumefantrine will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>aspirin<p>trazodone, aspirin.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>aspirin rectal<p>trazodone, aspirin rectal.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>aspirin/citric acid/sodium bicarbonate<p>trazodone, aspirin/citric acid/sodium bicarbonate.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>atazanavir<p>atazanavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>atazanavir increases levels of trazodone by unspecified interaction mechanism. Use Caution/Monitor.</p></li><li>atorvastatin<p>trazodone will decrease the level or effect of atorvastatin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>atracurium<p>atracurium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>atropine iv/im<p>atropine iv/im and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>axitinib<p>trazodone increases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>azelastine<p>azelastine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>azithromycin<p>trazodone will decrease the level or effect of azithromycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone and azithromycin both increase  QTc interval. Use Caution/Monitor.</p></li><li>baclofen<p>baclofen and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>bambuterol<p>trazodone increases and bambuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>bazedoxifene/conjugated estrogens<p>trazodone will decrease the level or effect of bazedoxifene/conjugated estrogens by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>belladonna and opium<p>belladonna and opium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>belladonna and opium and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>benperidol<p>benperidol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>benzphetamine<p>trazodone increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>boceprevir<p>boceprevir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Plasma concentrations of trazodone may increase when administered with boceprevir, resulting in adverse events such as dizziness, hypotension and syncope. Use with caution and consider a lower dose of trazodone.</p></li><li>brexpiprazole<p>trazodone will increase the level or effect of brexpiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Administer a quarter of brexpiprazole dose if coadministered with a moderate CYP2D6 inhibitor PLUS a strong/moderate CYP3A4 inhibitor.</p></li><li>brompheniramine<p>brompheniramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>buclizine<p>buclizine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>budesonide<p>budesonide will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of budesonide by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>buprenorphine<p>buprenorphine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>buprenorphine buccal<p>buprenorphine buccal and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>buprenorphine subdermal implant<p>trazodone, buprenorphine subdermal implant.
Either increases toxicity of the other by serotonin levels. Use Caution/Monitor. Concomitant use could result in life-threatening serotonin syndrome. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation, and during dose adjustment of the serotonergic drug. Discontinue buprenorphine if serotonin syndrome is suspected.</p></li><li>butabarbital<p>butabarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>butabarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>butalbital<p>butalbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>butalbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>butorphanol<p>butorphanol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>caffeine<p>trazodone increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>carbamazepine<p>carbamazepine will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will increase the level or effect of carbamazepine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Monitor plasma levels when used concomitantly</p></li><li>carbinoxamine<p>carbinoxamine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>carisoprodol<p>carisoprodol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>celecoxib<p>trazodone, celecoxib.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>chloral hydrate<p>chloral hydrate and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>chlordiazepoxide<p>chlordiazepoxide and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpheniramine<p>chlorpheniramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpromazine<p>chlorpromazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>chlorzoxazone<p>chlorzoxazone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>choline magnesium trisalicylate<p>trazodone, choline magnesium trisalicylate.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>cinnarizine<p>cinnarizine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>citalopram<p>citalopram and trazodone both increase  serotonin levels. Use Caution/Monitor. Combination may increase risk of serotonin syndrome or neuroleptic malignant syndrome-like reactions.</p></li><li>clemastine<p>clemastine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>clobetasone<p>clobetasone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of clobetasone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>clomethiazole<p>trazodone and clomethiazole both increase  sedation. Use Caution/Monitor.</p></li><li>clomipramine<p>clomipramine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>clomipramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>clonazepam<p>clonazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>clorazepate<p>clorazepate and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>clozapine<p>clozapine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>cobicistat<p>cobicistat will increase the level or effect of trazodone by  Other (see comment). Use Caution/Monitor. Trazodone is a substrate of CYP3A4 and CYP2D6; cobicistat inhibits CYP3A4 and CYP2D6 </p></li><li>cocaine<p>trazodone and cocaine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>codeine<p>codeine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>colchicine<p>trazodone will decrease the level or effect of colchicine by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>conjugated estrogens<p>trazodone will decrease the level or effect of conjugated estrogens by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>conjugated estrogens, vaginal<p>trazodone will decrease the level or effect of conjugated estrogens, vaginal by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>cortisone<p>cortisone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of cortisone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>crizotinib<p>crizotinib increases levels of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Dose reduction may be needed for coadministered drugs that are predominantly metabolized by CYP3A.</p></li><li>crofelemer<p>crofelemer increases levels of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Crofelemer has the potential to inhibit CYP3A4 at concentrations expected in the gut; unlikely to inhibit systemically because minimally absorbed.</p></li><li>cyclizine<p>cyclizine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>cyclobenzaprine<p>cyclobenzaprine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>cyclosporine<p>cyclosporine will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of cyclosporine by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>cyproheptadine<p>cyproheptadine and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone increases and cyproheptadine decreases serotonin levels. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>dabrafenib<p>dabrafenib will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.</p></li><li>dantrolene<p>dantrolene and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>darifenacin<p>darifenacin will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>darunavir<p>darunavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>dasatinib<p>dasatinib will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone and dasatinib both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>daunorubicin<p>trazodone will decrease the level or effect of daunorubicin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>daunorubicin liposomal<p>trazodone will decrease the level or effect of daunorubicin liposomal by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>debrisoquine<p>trazodone decreases effects of debrisoquine by Other (see comment). Use Caution/Monitor. 
Comment: Inhibition of uptake by adrenergic neurons.</p></li><li>deferasirox<p>deferasirox will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>deflazacort<p>trazodone will decrease the level or effect of deflazacort by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>delavirdine<p>delavirdine will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.</p></li><li>desflurane<p>desflurane and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>desipramine<p>desipramine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>desipramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>dexamethasone<p>dexamethasone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of dexamethasone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>dexchlorpheniramine<p>dexchlorpheniramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>dexfenfluramine<p>trazodone increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone and dexfenfluramine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>dexmedetomidine<p>dexmedetomidine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>dexmethylphenidate<p>trazodone increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dextroamphetamine<p>trazodone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>trazodone increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>dextromoramide<p>dextromoramide and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diamorphine<p>diamorphine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diazepam<p>diazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diclofenac<p>trazodone, diclofenac.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>diethylpropion<p>trazodone increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>difenoxin hcl<p>difenoxin hcl and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diflunisal<p>trazodone, diflunisal.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>digoxin<p>trazodone will decrease the level or effect of digoxin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone increases levels of digoxin by unspecified interaction mechanism. Use Caution/Monitor.</p></li><li>dihydroergotamine<p>trazodone and dihydroergotamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>dihydroergotamine intranasal<p>trazodone and dihydroergotamine intranasal both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>diltiazem<p>diltiazem will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>dimenhydrinate<p>dimenhydrinate and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diphenhydramine<p>diphenhydramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>diphenoxylate hcl<p>diphenoxylate hcl and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>dipipanone<p>dipipanone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>distigmine<p>distigmine increases and trazodone decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dobutamine<p>trazodone increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>docetaxel<p>trazodone will decrease the level or effect of docetaxel by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>dolasetron<p>trazodone and dolasetron both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>dopamine<p>trazodone increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dopexamine<p>trazodone increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dosulepin<p>dosulepin and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>dosulepin and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>doxepin<p>doxepin and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>doxepin and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>doxorubicin<p>trazodone will decrease the level or effect of doxorubicin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>doxorubicin liposomal<p>trazodone will decrease the level or effect of doxorubicin liposomal by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>doxylamine<p>doxylamine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>dronedarone<p>dronedarone will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>droperidol<p>droperidol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>efavirenz<p>efavirenz will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>eletriptan<p>eletriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>elvitegravir/cobicistat/emtricitabine/tenofovir df<p>elvitegravir/cobicistat/emtricitabine/tenofovir df increases levels of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Cobicistat is a CYP3A4 inhibitor; contraindicated with CYP3A4 substrates for which elevated plasma concentrations are associated with serious and/or life-threatening events.</p></li><li>enflurane<p>enflurane and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>ephedrine<p>trazodone increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone increases effects of ephedrine by unknown mechanism. Use Caution/Monitor.</p></li><li>ephedrine (pulmonary)<p>trazodone increases and ephedrine (pulmonary) decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .<span><br><br></span>trazodone increases effects of ephedrine (pulmonary) by unknown mechanism. Use Caution/Monitor.</p></li><li>epinephrine<p>trazodone increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone increases effects of epinephrine by unknown mechanism. Use Caution/Monitor.</p></li><li>epinephrine racemic<p>trazodone increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone increases effects of epinephrine racemic by unknown mechanism. Use Caution/Monitor.</p></li><li>ergotamine<p>trazodone and ergotamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>erythromycin base<p>erythromycin base will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>erythromycin ethylsuccinate<p>erythromycin ethylsuccinate will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>erythromycin lactobionate<p>erythromycin lactobionate will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>erythromycin stearate<p>erythromycin stearate will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>eslicarbazepine acetate<p>eslicarbazepine acetate will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>estazolam<p>estazolam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>estradiol<p>trazodone will decrease the level or effect of estradiol by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>estrogens conjugated synthetic<p>trazodone will decrease the level or effect of estrogens conjugated synthetic by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>estropipate<p>trazodone will decrease the level or effect of estropipate by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ethanol<p>trazodone and ethanol both increase  sedation. Use Caution/Monitor.</p></li><li>ethotoin<p>ethotoin will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>etodolac<p>trazodone, etodolac.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>etomidate<p>etomidate and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>etoposide<p>trazodone will decrease the level or effect of etoposide by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>etoricoxib<p>trazodone, etoricoxib.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>eucalyptus<p>eucalyptus will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>everolimus<p>trazodone will decrease the level or effect of everolimus by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>fenbufen<p>trazodone, fenbufen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>fenfluramine<p>trazodone increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone and fenfluramine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>fenoprofen<p>trazodone, fenoprofen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>flecainide<p>trazodone and flecainide both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>flibanserin<p>trazodone will increase the level or effect of flibanserin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors.</p></li><li>fluconazole<p>fluconazole will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>fludrocortisone<p>fludrocortisone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of fludrocortisone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>fluoxetine<p>trazodone and fluoxetine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>fluphenazine<p>fluphenazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>flurazepam<p>flurazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>flurbiprofen<p>trazodone, flurbiprofen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>fluvoxamine<p>trazodone and fluvoxamine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>formoterol<p>trazodone increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fosamprenavir<p>fosamprenavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.</p></li><li>foscarnet<p>trazodone and foscarnet both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>fosphenytoin<p>fosphenytoin will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>fospropofol<p>fospropofol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>frovatriptan<p>frovatriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>gentamicin<p>trazodone will decrease the level or effect of gentamicin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>goserelin<p>goserelin increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.</p></li><li>grapefruit<p>grapefruit will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>green tea<p>green tea, trazodone. Other (see comment). Use Caution/Monitor. 
Comment: Combination may increase risk of bleeding.</p></li><li>griseofulvin<p>griseofulvin will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>haloperidol<p>haloperidol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>henbane<p>henbane and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hexobarbital<p>hexobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>hexobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>histrelin<p>histrelin increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.</p></li><li>homatropine<p>homatropine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>huperzine a<p>huperzine a increases and trazodone decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hydrocodone<p>hydrocodone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>hydrocortisone<p>hydrocortisone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of hydrocortisone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>hydromorphone<p>hydromorphone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>hydroxyzine<p>hydroxyzine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>hyoscyamine<p>hyoscyamine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hyoscyamine spray<p>hyoscyamine spray and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>ibuprofen<p>trazodone, ibuprofen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>iloperidone<p>trazodone and iloperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>iloperidone and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>iloperidone increases levels of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Iloperidone is a time-dependent CYP3A inhibitor and may lead to increased plasma levels of drugs predominantly eliminated by CYP3A4.</p></li><li>imatinib<p>trazodone will decrease the level or effect of imatinib by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>imipramine<p>imipramine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>imipramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>incobotulinumtoxina<p>incobotulinumtoxina and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>indinavir<p>indinavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>trazodone will decrease the level or effect of indinavir by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>indomethacin<p>trazodone, indomethacin.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>ipratropium<p>ipratropium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>irinotecan liposomal<p>trazodone will decrease the level or effect of irinotecan liposomal by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>isoniazid<p>isoniazid will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone and isoniazid both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>isoproterenol<p>trazodone increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>itraconazole<p>trazodone will decrease the level or effect of itraconazole by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ivermectin<p>trazodone will decrease the level or effect of ivermectin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>kanamycin<p>trazodone will decrease the level or effect of kanamycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ketamine<p>ketamine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>ketoprofen<p>trazodone, ketoprofen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>ketorolac<p>trazodone, ketorolac.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>ketorolac intranasal<p>trazodone, ketorolac intranasal.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>ketotifen, ophthalmic<p>trazodone and ketotifen, ophthalmic both increase  sedation. Use Caution/Monitor.</p></li><li>l-tryptophan<p>trazodone and l-tryptophan both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lapatinib<p>lapatinib will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of lapatinib by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone and lapatinib both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>lenvatinib<p>trazodone and lenvatinib both increase  QTc interval. Use Caution/Monitor. Lenvatinib prescribing information recommends monitoring ECG closely when coadministered with QT prolonging drugs.</p></li><li>leuprolide<p>leuprolide increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.</p></li><li>levalbuterol<p>trazodone increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>levofloxacin<p>trazodone and levofloxacin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>levorphanol<p>levorphanol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>linagliptin<p>trazodone will decrease the level or effect of linagliptin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. Use of alternative treatments is strongly recommended when linagliptin is to be administered with a P-gp inducer.</p></li><li>lisdexamfetamine<p>trazodone increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lithium<p>trazodone and lithium both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lofepramine<p>lofepramine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>lofepramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>lofexidine<p>trazodone and lofexidine both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone decreases effects of lofexidine by unspecified interaction mechanism. Use Caution/Monitor.</p></li><li>lomitapide<p>trazodone increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Lomitapide dose should not exceed 30 mg/day.</p></li><li>loperamide<p>trazodone will decrease the level or effect of loperamide by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>loprazolam<p>loprazolam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>lorazepam<p>lorazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>lormetazepam<p>lormetazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>lornoxicam<p>trazodone, lornoxicam.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>lovastatin<p>trazodone will decrease the level or effect of lovastatin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>loxapine<p>loxapine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>loxapine inhaled<p>loxapine inhaled and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>lsd<p>trazodone and lsd both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lumefantrine<p>lumefantrine will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>lurasidone<p>lurasidone, trazodone.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.</p></li><li>maprotiline<p>maprotiline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>maprotiline and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>maraviroc<p>trazodone will decrease the level or effect of maraviroc by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>marijuana<p>marijuana will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone and marijuana both increase  sedation. Use Caution/Monitor.</p></li><li>meclizine<p>meclizine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>meclofenamate<p>trazodone, meclofenamate.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>mefenamic acid<p>trazodone, mefenamic acid.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>melatonin<p>trazodone and melatonin both increase  sedation. Use Caution/Monitor.</p></li><li>meloxicam<p>trazodone, meloxicam.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>mepenzolate<p>mepenzolate and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>meperidine<p>meperidine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>mephobarbital<p>mephobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>mephobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>meprobamate<p>trazodone and meprobamate both increase  sedation. Use Caution/Monitor.</p></li><li>mestranol<p>trazodone will decrease the level or effect of mestranol by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>metaproterenol<p>trazodone increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metaxalone<p>metaxalone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>methadone<p>trazodone and methadone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>methadone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>methamphetamine<p>trazodone increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. trazodone increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Significant - Monitor Closely..<span><br><br></span>methamphetamine increases toxicity of trazodone by Other (see comment). Use Caution/Monitor. 
Comment: Amphetamines may increase the toxicity of serotonin modulators, increasing the risk of serotonin syndrome. .</p></li><li>methocarbamol<p>methocarbamol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>methscopolamine<p>methscopolamine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>methylenedioxymethamphetamine<p>trazodone increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methylphenidate<p>trazodone increases and methylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methylprednisolone<p>methylprednisolone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of methylprednisolone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>metronidazole<p>metronidazole will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>mianserin<p>mianserin and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>mianserin and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>mibefradil<p>mibefradil will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>miconazole vaginal<p>miconazole vaginal will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>midazolam<p>midazolam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>midodrine<p>trazodone increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>mipomersen<p>mipomersen, trazodone.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Both drugs have potential to increase hepatic enzymes; monitor LFTs.</p></li><li>mirtazapine<p>trazodone and mirtazapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone and mirtazapine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>mitotane<p>mitotane decreases levels of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Mitotane is a strong inducer of cytochrome P-4503A4; monitor when coadministered with CYP3A4 substrates for possible dosage adjustments.</p></li><li>modafinil<p>modafinil will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>morphine<p>morphine and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone and morphine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>motherwort<p>trazodone and motherwort both increase  sedation. Use Caution/Monitor.</p></li><li>moxonidine<p>trazodone and moxonidine both increase  sedation. Use Caution/Monitor.</p></li><li>mycophenolate<p>trazodone will decrease the level or effect of mycophenolate by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>nabilone<p>trazodone and nabilone both increase  sedation. Use Caution/Monitor.</p></li><li>nabumetone<p>trazodone, nabumetone.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>nafarelin<p>nafarelin increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.</p></li><li>nafcillin<p>nafcillin will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>nalbuphine<p>nalbuphine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>naproxen<p>trazodone, naproxen.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>naratriptan<p>naratriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>nefopam<p>nefopam, trazodone. Mechanism: unspecified interaction mechanism. Use Caution/Monitor. Use combination with caution.</p></li><li>nelfinavir<p>nelfinavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of nelfinavir by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>neomycin po<p>trazodone will decrease the level or effect of neomycin po by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>netilmicin<p>trazodone will decrease the level or effect of netilmicin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>nifedipine<p>nifedipine will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>nilotinib<p>nilotinib will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of nilotinib by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>norepinephrine<p>trazodone increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone increases effects of norepinephrine by unknown mechanism. Use Caution/Monitor.</p></li><li>nortriptyline<p>trazodone will decrease the level or effect of nortriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>nortriptyline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>nortriptyline and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>ofloxacin<p>trazodone and ofloxacin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>olanzapine<p>olanzapine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>opium tincture<p>opium tincture and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>orphenadrine<p>trazodone and orphenadrine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>orphenadrine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>oxaprozin<p>trazodone, oxaprozin.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>oxazepam<p>oxazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>oxcarbazepine<p>oxcarbazepine will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>oxiconazole<p>oxiconazole will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>oxybutynin<p>oxybutynin and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin topical<p>oxybutynin topical and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin transdermal<p>oxybutynin transdermal and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxycodone<p>oxycodone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>oxymorphone<p>oxymorphone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>paclitaxel<p>trazodone will decrease the level or effect of paclitaxel by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>paclitaxel protein bound<p>trazodone will decrease the level or effect of paclitaxel protein bound by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>paliperidone<p>trazodone will decrease the level or effect of paliperidone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone and paliperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>paliperidone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>pancuronium<p>pancuronium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>papaveretum<p>papaveretum and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>papaverine<p>trazodone and papaverine both increase  sedation. Use Caution/Monitor.</p></li><li>parecoxib<p>trazodone, parecoxib.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>paromomycin<p>trazodone will decrease the level or effect of paromomycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>paroxetine<p>trazodone and paroxetine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>pazopanib<p>trazodone and pazopanib both increase  QTc interval. Use Caution/Monitor.</p></li><li>peginterferon alfa 2b<p>peginterferon alfa 2b, trazodone. Other (see comment). Use Caution/Monitor. 
Comment: When patients are administered peginterferon alpha-2b with CYP2D6 substrates, the therapeutic effect of these drugs may be altered. Peginterferon alpha-2b may increase or decrease levels of CYP2D6 substrate.</p></li><li>pentazocine<p>pentazocine and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone and pentazocine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>pentobarbital<p>pentobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>pentobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>perphenazine<p>perphenazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>phendimetrazine<p>trazodone increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>phenobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>phentermine<p>trazodone increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine<p>trazodone increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine ophthalmic<p>trazodone, phenylephrine ophthalmic. Other (see comment). Use Caution/Monitor. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>phenylephrine po<p>trazodone increases and phenylephrine po decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>pholcodine<p>trazodone and pholcodine both increase  sedation. Use Caution/Monitor.</p></li><li>pimozide<p>pimozide and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>pirbuterol<p>trazodone increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>piroxicam<p>trazodone, piroxicam.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>posaconazole<p>trazodone will decrease the level or effect of posaconazole by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone and posaconazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>pralidoxime<p>pralidoxime and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>prednisolone<p>prednisolone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of prednisolone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>prednisone<p>prednisone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of prednisone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>primidone<p>primidone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>primidone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>prochlorperazine<p>prochlorperazine and trazodone both increase  QTc interval. Use Caution/Monitor.<span><br><br></span>prochlorperazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>promethazine<p>promethazine and trazodone both increase  QTc interval. Use Caution/Monitor.<span><br><br></span>promethazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>propantheline<p>propantheline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>propofol<p>propofol and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>propylhexedrine<p>trazodone increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>protriptyline<p>protriptyline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>protriptyline and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>pseudoephedrine<p>trazodone increases and pseudoephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>quazepam<p>quazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>quetiapine<p>quetiapine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>quinupristin/dalfopristin<p>quinupristin/dalfopristin will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>ramelteon<p>trazodone and ramelteon both increase  sedation. Use Caution/Monitor.</p></li><li>ranolazine<p>trazodone and ranolazine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>rapacuronium<p>rapacuronium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>rifabutin<p>rifabutin decreases levels of trazodone by increasing metabolism. Use Caution/Monitor.</p></li><li>rimabotulinumtoxinb<p>rimabotulinumtoxinb and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>risperidone<p>trazodone will decrease the level or effect of risperidone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>trazodone and risperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>risperidone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>ritonavir<p>ritonavir will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>trazodone will decrease the level or effect of ritonavir by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>rizatriptan<p>rizatriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>rocuronium<p>rocuronium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>romidepsin<p>trazodone will decrease the level or effect of romidepsin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>rufinamide<p>rufinamide will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>salicylates (non-asa)<p>trazodone, salicylates (non-asa).
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>salmeterol<p>trazodone increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>salsalate<p>trazodone, salsalate.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>same<p>trazodone and same both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>scopolamine<p>scopolamine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>scullcap<p>trazodone and scullcap both increase  sedation. Use Caution/Monitor.</p></li><li>secobarbital<p>secobarbital will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>secobarbital and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>sertindole<p>sertindole and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>sevoflurane<p>sevoflurane and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>shepherd's purse<p>trazodone and shepherd's purse both increase  sedation. Use Caution/Monitor.</p></li><li>silodosin<p>trazodone will decrease the level or effect of silodosin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>sirolimus<p>trazodone will decrease the level or effect of sirolimus by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>sitaxentan<p>sitaxentan will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>solifenacin<p>solifenacin and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>streptomycin<p>trazodone will decrease the level or effect of streptomycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>sufentanil<p>sufentanil and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>sulfamethoxazole<p>trazodone and sulfamethoxazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>sulfasalazine<p>trazodone, sulfasalazine.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>sulindac<p>trazodone, sulindac.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>sulpiride<p>sulpiride and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>sumatriptan<p>sumatriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>sumatriptan intranasal<p>sumatriptan intranasal and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>sumatriptan transdermal<p>sumatriptan transdermal and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>tacrolimus<p>trazodone will decrease the level or effect of tacrolimus by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>tamsulosin<p>trazodone increases levels of tamsulosin by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tapentadol<p>tapentadol and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone and tapentadol both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>telaprevir<p>telaprevir increases levels of trazodone by Other (see comment). Use Caution/Monitor. 
Comment: Concomitant use of trazodone and telaprevir may increase plasma concentrations of trazodone which may lead to adverse events such as nausea, dizziness, hypotension and syncope. If trazodone is used with telaprevir, the combination should be used with caution and a lower dose of trazodone should be considered.</p></li><li>telavancin<p>trazodone and telavancin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>telithromycin<p>telithromycin will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone and telithromycin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>temazepam<p>temazepam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>terbutaline<p>trazodone increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>terfenadine<p>terfenadine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>thioridazine<p>thioridazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>thiothixene<p>thiothixene and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>tiotropium<p>tiotropium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tobramycin<p>trazodone will decrease the level or effect of tobramycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>tolfenamic acid<p>trazodone, tolfenamic acid.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>tolmetin<p>trazodone, tolmetin.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of upper GI bleeding. SSRIs inhib. serotonin uptake by platelets.</p></li><li>tolterodine<p>tolterodine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tolvaptan<p>trazodone will decrease the level or effect of tolvaptan by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>topiramate<p>topiramate will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone and topiramate both increase  sedation. Modify Therapy/Monitor Closely.</p></li><li>tramadol<p>tramadol and trazodone both increase  sedation. Use Caution/Monitor.<span><br><br></span>trazodone and tramadol both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>triamcinolone<p>triamcinolone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>trazodone will decrease the level or effect of triamcinolone by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>triazolam<p>triazolam and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>triclofos<p>triclofos and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>trifluoperazine<p>trifluoperazine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>trimethoprim<p>trazodone and trimethoprim both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>trimipramine<p>trazodone and trimipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>trazodone and trimipramine both increase  sedation. Use Caution/Monitor.</p></li><li>triptorelin<p>triptorelin increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.</p></li><li>troglitazone<p>troglitazone will decrease the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>troleandomycin<p>troleandomycin will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>tropisetron<p>trazodone and tropisetron both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>trospium chloride<p>trospium chloride and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tubocurarine<p>tubocurarine and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>vecuronium<p>vecuronium and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>venlafaxine<p>trazodone and venlafaxine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>verapamil<p>verapamil will increase the level or effect of trazodone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>vinblastine<p>trazodone will decrease the level or effect of vinblastine by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>vincristine<p>trazodone will decrease the level or effect of vincristine by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>vincristine liposomal<p>trazodone will decrease the level or effect of vincristine liposomal by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>voriconazole<p>trazodone and voriconazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>xylometazoline<p>trazodone increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>yohimbine<p>trazodone increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ziconotide<p>trazodone and ziconotide both increase  sedation. Use Caution/Monitor.</p></li><li>ziprasidone<p>ziprasidone and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>zolmitriptan<p>zolmitriptan and trazodone both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>zotepine<p>zotepine and trazodone both increase  sedation. Use Caution/Monitor.</p></li>